Atossa Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Atossa Genetics
ATOS Stock  USD 0.58  0.02  3.25%   
Atossa Genetics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Atossa Genetics' valuation are provided below:
Market Capitalization
77.8 M
Earnings Share
(0.23)
There are over one hundred nineteen available fundamental signals for Atossa Genetics, which can be analyzed over time and compared to other ratios. All traders should validate Atossa Genetics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 112.3 M in 2026. Enterprise Value is likely to gain to about 57.6 M in 2026

Atossa Genetics Total Revenue

0.0

Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Other Operating Expenses of 33.4 M, Research Development of 17 M or Total Operating Expenses of 33.4 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.82. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
  
Build AI portfolio with Atossa Stock
Check out the analysis of Atossa Genetics Correlation against competitors.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Atossa Genetics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets92.3 M87.9 M43.5 M
Slightly volatile
Short and Long Term Debt Total15.4 K16.2 K91.2 K
Slightly volatile
Other Current Liabilities2.7 M4.9 M2.7 M
Slightly volatile
Total Current Liabilities3.5 M5.7 M3.5 M
Slightly volatile
Total Stockholder Equity86.3 M82.2 M39.8 M
Slightly volatile
Cash85.8 M81.7 M39.4 M
Slightly volatile
Non Current Assets Total1.9 M2.3 M1.8 M
Very volatile
Non Currrent Assets Other2.4 M2.3 M624.2 K
Slightly volatile
Cash And Short Term Investments85.8 M81.7 M39.4 M
Slightly volatile
Common Stock Shares Outstanding152 M144.7 M48.1 M
Slightly volatile
Liabilities And Stockholders Equity92.3 M87.9 M43.5 M
Slightly volatile
Other Stockholder Equity313.7 M298.7 M130.9 M
Slightly volatile
Total Liabilities3.5 M5.7 M3.5 M
Slightly volatile
Total Current Assets89.9 M85.6 M41.6 M
Slightly volatile
Short Term Debt15.4 K16.2 K83.8 K
Slightly volatile
Common Stock28.4 M27 M9.4 M
Slightly volatile
Common Stock Total Equity27.5 M26.2 M9.5 M
Slightly volatile
Property Plant And Equipment Net17.1 K18 K80.8 K
Slightly volatile
Accounts Payable828.4 K780.9 K718.6 K
Slightly volatile
Other Current Assets4.1 M3.9 M1.5 M
Slightly volatile
Property Plant And Equipment Gross30.8 K32.4 K85.1 K
Slightly volatile
Intangible Assets11.4 K12 K806.7 K
Slightly volatile
Property Plant Equipment17.1 K18 K77.9 K
Slightly volatile
Net Tangible Assets142.4 M135.7 M50.9 M
Slightly volatile
Capital Surpluse303.5 M289.1 M131.1 M
Slightly volatile
Current Deferred Revenue985.6 K1.2 M827.5 K
Slightly volatile
Other Liabilities1.6 K1.8 K2 K
Slightly volatile
Net Invested Capital65.3 M82.2 M39.5 M
Slightly volatile
Net Working Capital63.6 M79.9 M38.4 M
Slightly volatile
Capital Stock16.2 M27 M9.1 M
Slightly volatile

Atossa Genetics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses33.4 M31.8 M16.2 M
Slightly volatile
Research Development17 M16.2 M6.8 M
Slightly volatile
Total Operating Expenses33.4 M31.8 M16.2 M
Slightly volatile
Depreciation And Amortization14.5 K15.3 K125.5 K
Slightly volatile
Selling General Administrative9.1 M15.5 M8.7 M
Slightly volatile
Selling And Marketing Expenses16.9 M16.1 M9.6 M
Slightly volatile
Cost Of Revenue14.5 K15.3 K112.1 K
Slightly volatile
Non Recurring394.8 K415.5 K1 M
Slightly volatile
Interest Income4.9 M4.7 M1.2 M
Slightly volatile
Preferred Stock And Other Adjustments2.1 M2.3 M2.5 M
Slightly volatile
Reconciled Depreciation14.5 K15.3 K74.4 K
Slightly volatile

Atossa Genetics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.8 M2.6 M2.6 M
Slightly volatile
Begin Period Cash Flow106.9 M101.9 M37.7 M
Slightly volatile
End Period Cash Flow86 M81.9 M39.4 M
Slightly volatile
Depreciation14.5 K15.3 K126.4 K
Slightly volatile
Change To Netincome8.2 M7.8 M3.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.6 K6 K7.3 K
Slightly volatile
PTB Ratio1.821.9184.9189
Slightly volatile
Days Sales Outstanding190238205
Very volatile
Book Value Per Share0.620.6520.8676
Slightly volatile
Average Payables1.6 M1.5 M812.6 K
Slightly volatile
Stock Based Compensation To Revenue452430344
Slightly volatile
Capex To Depreciation1.721.292.0342
Slightly volatile
PB Ratio1.821.9184.9189
Slightly volatile
EV To Sales7 K3.5 K5.8 K
Slightly volatile
Inventory Turnover0.07790.0821.6352
Slightly volatile
Days Of Inventory On Hand4.8 K4.6 K3.3 K
Slightly volatile
Payables Turnover0.140.12513.4625
Slightly volatile
Sales General And Administrative To Revenue4.8 K4.5 K3.8 K
Slightly volatile
Average Inventory425 K356.4 K400.4 K
Slightly volatile
Research And Ddevelopement To Revenue1.3 K1.2 K936
Slightly volatile
Capex To Revenue89.885.5264.8976
Slightly volatile
Cash Per Share0.620.6515.1199
Slightly volatile
Days Payables Outstanding2.8 K2.6 K1.8 K
Slightly volatile
Income Quality0.610.740.7532
Very volatile
Intangibles To Total Assets3.0E-44.0E-40.0993
Slightly volatile
Net Debt To EBITDA1.242.321.6737
Slightly volatile
Current Ratio7.113.499.5578
Slightly volatile
Tangible Book Value Per Share0.620.6512.2297
Slightly volatile
Receivables Turnover2.191.591.9763
Pretty Stable
Shareholders Equity Per Share0.620.6520.8676
Slightly volatile
Debt To Equity7.0E-48.0E-40.0496
Slightly volatile
Capex Per Share2.0E-42.0E-40.9728
Slightly volatile
Graham Net Net0.570.69.4465
Slightly volatile
Average Receivables594.3 K566 K390.2 K
Slightly volatile
Revenue Per Share0.01220.01281.0854
Slightly volatile
Interest Debt Per Share0.00170.00181.3164
Slightly volatile
Debt To Assets5.0E-45.0E-40.0247
Slightly volatile
Operating Cycle4.8 K4.6 K3.3 K
Slightly volatile
Price Book Value Ratio1.821.9184.9189
Slightly volatile
Days Of Payables Outstanding2.8 K2.6 K1.8 K
Slightly volatile
Ebt Per Ebit1.11.061.0066
Pretty Stable
Company Equity Multiplier1.431.231.3769
Slightly volatile
Total Debt To Capitalization7.0E-48.0E-40.0335
Slightly volatile
Debt Equity Ratio7.0E-48.0E-40.0496
Slightly volatile
Quick Ratio6.9813.499.4102
Slightly volatile
Net Income Per E B T0.91.111.1944
Pretty Stable
Cash Ratio6.6512.888.9679
Slightly volatile
Days Of Inventory Outstanding4.8 K4.6 K3.3 K
Slightly volatile
Days Of Sales Outstanding190238205
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0295
Pretty Stable
Price To Book Ratio1.821.9184.9189
Slightly volatile
Fixed Asset Turnover0.01120.01180.5014
Slightly volatile
Debt Ratio5.0E-45.0E-40.0247
Slightly volatile
Price Sales Ratio7.6 K6 K7.3 K
Slightly volatile
Asset Turnover3.0E-43.0E-40.0101
Slightly volatile
Price Fair Value1.821.9184.9189
Slightly volatile

Atossa Genetics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap112.3 M106.9 M53.7 M
Slightly volatile

Atossa Fundamental Market Drivers

Atossa Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.2 M985.6 K
Cost Of Revenue15.3 K14.5 K
Stock Based Compensation To Revenue 430.09  451.59 
Sales General And Administrative To Revenue4.5 K4.8 K
Research And Ddevelopement To Revenue1.2 K1.3 K
Capex To Revenue 85.52  89.80 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-8.3 K-7.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY